» Articles » PMID: 28542144

Dicer and MicroRNAs Protect Adult Dopamine Neurons

Overview
Journal Cell Death Dis
Date 2017 May 26
PMID 28542144
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRs) are important post-transcriptional regulators of gene expression implicated in neuronal development, differentiation, aging and neurodegenerative diseases, including Parkinson's disease (PD). Several miRs have been linked to PD-associated genes, apoptosis and stress response pathways, suggesting that deregulation of miRs may contribute to the development of the neurodegenerative phenotype. Here, we investigate the cell-autonomous role of miR processing RNAse Dicer in the functional maintenance of adult dopamine (DA) neurons. We demonstrate a reduction of Dicer in the ventral midbrain and altered miR expression profiles in laser-microdissected DA neurons of aged mice. Using a mouse line expressing tamoxifen-inducible CreERT2 recombinase under control of the DA transporter promoter, we show that a tissue-specific conditional ablation of Dicer in DA neurons of adult mice led to decreased levels of striatal DA and its metabolites without a reduction in neuronal body numbers in hemizygous mice (Dicer) and to progressive loss of DA neurons with severe locomotor deficits in nullizygous mice (Dicer). Moreover, we show that pharmacological stimulation of miR biosynthesis promoted survival of cultured DA neurons and reduced their vulnerability to thapsigargin-induced endoplasmic reticulum stress. Our data demonstrate that Dicer is crucial for maintenance of adult DA neurons, whereas a stimulation of miR production can promote neuronal survival, which may have direct implications for PD treatment.

Citing Articles

MicroRNA biogenesis pathway alterations in aging.

Sanz-Ros J, Mas-Bargues C, Romero-Garcia N, Huete-Acevedo J, Dromant M, Borras C Extracell Vesicles Circ Nucl Acids. 2024; 4(3):486-501.

PMID: 39698023 PMC: 11648461. DOI: 10.20517/evcna.2023.29.


A review on gut microbiota and miRNA crosstalk: implications for Alzheimer's disease.

Ayyanar M, Vijayan M Geroscience. 2024; 47(1):339-385.

PMID: 39562408 PMC: 11872870. DOI: 10.1007/s11357-024-01432-5.


Distinct fingerprints of tRNA-derived small non-coding RNA in animal models of neurodegeneration.

Baindoor S, Gibriel H, Veno M, Su J, Morrissey E, Jirstrom E Dis Model Mech. 2024; 17(11).

PMID: 39552337 PMC: 11603119. DOI: 10.1242/dmm.050870.


Sample-to-answer salivary miRNA testing: New frontiers in point-of-care diagnostic technologies.

Zhang Z, Liu T, Dong M, Ahamed M, Guan W Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024; 16(3):e1969.

PMID: 38783564 PMC: 11141732. DOI: 10.1002/wnan.1969.


An Intricate Network Involving the Argonaute ALG-1 Modulates Organismal Resistance to Oxidative Stress.

Vergani-Junior C, Moro R, Pinto S, De-Souza E, Camara H, Braga D Nat Commun. 2024; 15(1):3070.

PMID: 38594249 PMC: 11003958. DOI: 10.1038/s41467-024-47306-4.


References
1.
Heman-Ackah S, Hallegger M, Rao M, Wood M . RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis. Front Mol Neurosci. 2013; 6:40. PMC: 3834244. DOI: 10.3389/fnmol.2013.00040. View

2.
Inukai S, de Lencastre A, Turner M, Slack F . Novel microRNAs differentially expressed during aging in the mouse brain. PLoS One. 2012; 7(7):e40028. PMC: 3402511. DOI: 10.1371/journal.pone.0040028. View

3.
Kim J, Inoue K, Ishii J, Vanti W, Voronov S, Murchison E . A MicroRNA feedback circuit in midbrain dopamine neurons. Science. 2007; 317(5842):1220-4. PMC: 2782470. DOI: 10.1126/science.1140481. View

4.
Dhaene B, Mestdagh P, Hellemans J, Vandesompele J . miRNA expression profiling: from reference genes to global mean normalization. Methods Mol Biol. 2011; 822:261-72. DOI: 10.1007/978-1-61779-427-8_18. View

5.
Findley L . The economic impact of Parkinson's disease. Parkinsonism Relat Disord. 2007; 13 Suppl:S8-S12. DOI: 10.1016/j.parkreldis.2007.06.003. View